A GSH/CB Dual-Controlled Self-Assembled Nanomedicine for High-Efficacy Doxorubicin-Resistant Breast Cancer Therapy.

Yang, Yang; Zhao, Quanfeng; Peng, Zhe; Zhou, Yunjiang; Niu, Miao-Miao; Chen, Lin

Yang, Yang; Zhao, Quanfeng; Peng, Zhe; Zhou, Yunjiang; Niu, Miao-Miao; Chen, Lin.

Afiliação

Yang Y; Department of Pharmacology, Chongqing Health Center for Women and Children, Chongqing, China.
Zhao Q; Department of Pharmacy, Southwest Hospital, First Affiliated Hospital to TMMU, Third Military Medical University (Army Medical University), Chongqing, China.
Peng Z; Department of Pharmacology, Chongqing Health Center for Women and Children, Chongqing, China.
Zhou Y; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Niu MM; Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, State Key Laboratory of Natural Medicines, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
Chen L; Department of Pharmacology, Chongqing Health Center for Women and Children, Chongqing, China.

Front Pharmacol ; 12: 811724, 2021.

Article em En | MEDLINE | ID: mdl-35095524

Palavras-chave

GSH; breast cancer; cathepsin B; cyclic peptide; drug-resistance

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google